Norman Wolmark

121.7k citations
532 papers · 68.8k indexed · 36 hit papers · h-index 111

Impact in

  • Cancer Research top 0.01%
    • Breast Cancer Treatment Studies
  • Oncology top 0.01%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Surgical Treatments
    • Colorectal Cancer Treatments and Studies

Papers in

    • Breast Cancer Treatment Studies 252
    • Colorectal Cancer Treatments and Studies 140
    • Cancer Treatment and Pharmacology 123
    • HER2/EGFR in Cancer Research 105
    • Colorectal Cancer Surgical Treatments 76

Norman Wolmark

517 papers receiving 66.3k citations

Hit Papers

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial 2018 · 516 citations
516197520261992200950010001.5k

Peers

Norman Wolmark
Comparison fields: 5 of 179
  • Cancer Research 40.3k
  • Oncology 39.2k
  • Pathology and Forensic Medicine 21.8k
  • Genetics 11.0k
  • Surgery 14.8k
Replace Bernard Fisher with:
Bernard Fisher United States
Giuseppe Viale Italy
Gabriel N. Hortobágyi United States
Kelly K. Hunt United States
Umberto Veronesi Italy
Thomas A. Buchholz United States
Aman U. Buzdar United States
D. Lawrence Wickerham United States
Eric P. Winer United States
Edwin R. Fisher United States
Norman Wolmark relative to Bernard Fisher United States Bernard Fisher's profile →
Citations per field
00.5×1.5×2.4×
Bernard Fisher · 1×
Citations per year

Countries citing papers authored by Norman Wolmark

Since Specialization
Citations

This map shows the geographic impact of Norman Wolmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Wolmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Wolmark more than expected).

Fields of papers citing papers by Norman Wolmark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Wolmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Wolmark. The network helps show where Norman Wolmark may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Norman Wolmark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norman Wolmark Line = papers co-authored together Norman Wolmark links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20247
2 20240
3 20243
4 20224
5 201356
6 201292
7
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
Hit paper breakdown →
2012394
8 2012111
9 2012240
10 201210
11
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
Hit paper breakdown →
2011435
12 2010220
13 2010438
14 2010410
15 201010
16 200658
17
Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31
Hit paper breakdown →
2005568
18 2002447
19
Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
200041
20
Stapled Baker type anastomosis for low anterior resections.
19901

About Norman Wolmark

Norman Wolmark is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 532 papers that have together received 68.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (252 papers), Colorectal Cancer Treatments and Studies (140 papers), Cancer Treatment and Pharmacology (123 papers), HER2/EGFR in Cancer Research (105 papers), Colorectal Cancer Surgical Treatments (76 papers), Genetic factors in colorectal cancer (74 papers), Estrogen and related hormone effects (72 papers) and Breast Lesions and Carcinomas (65 papers). The work is most often cited by research in Cancer Research (40.3k citations), Oncology (39.2k citations), Pathology and Forensic Medicine (21.8k citations), Genetics (11.0k citations) and Surgery (14.8k citations). Norman Wolmark has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Bernard Fisher, D. Lawrence Wickerham, Edwin R. Fisher, Stewart Anderson, Richard G. Margolese, John Bryant, Eleftherios P. Mamounas, Carol Redmond, Joseph P. Costantino and Melvin Deutsch. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, JNCI Journal of the National Cancer Institute, Cancer and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026